Regulatory Aspects of Pharmacokinetic Profiling in Special Populations: A European Perspective

Author： Edholm Monica   Eva Gil Berglund   Salmonson Tomas  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.47, Iss.11, 2008-01, pp. : 693-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Management: A European Regulatory Perspective

By Moseley J.N.S.  

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 499-508

Adis International

Access to resources Recommend Favorite

Outstanding Regulatory Aspects in the European Pharmaceutical Market

By Kanavos P.   Mossialos E.  

PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. : 519-533

Adis International

Access to resources Recommend Favorite

The New European Regulation on Pediatric Medicines: Regulatory Perspective

By Hawcutt Daniel B.   Smyth Rosalind L.  

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 143-146

Adis International

Access to resources Recommend Favorite

Role of Modelling and Simulation: A European Regulatory Perspective

By Jönsson Siv   Henningsson Anja   Edholm Monica   Salmonson Tomas  

Clinical Pharmacokinetics, Vol. 51, Iss. 2, 2012-02 ,pp. : 69-76

Adis International

Access to resources Recommend Favorite

A Swedish Regulatory Perspective on European Risk Management

By Hedenmalm Karin   Alvan Gunnar  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 2, 2007-01 ,pp. : 131-145

Adis International

Access to resources Recommend Favorite